YTHDF2 and neoplasm: Although the disparities existed in different tumor types, the aberrant expression of YTHDF2 has been proposed to be a promising prognosis predictive factor in some cancer types, including ACC, LGG, KICH, KIRP, LIHC, KIRC, and READ, based on both single-factor Cox regression analysis and Kaplan-Meier survival analyses.